Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
127,443,399
-
Share change
-
-7,473,560
-
Total reported value
-
$424,229,640
-
Put/Call ratio
-
171%
-
Price per share
-
$3.33
-
Number of holders
-
185
-
Value change
-
-$26,278,429
-
Number of buys
-
90
-
Number of sells
-
86
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q1 2016
As of 31 Mar 2016,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
185 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,443,399 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., Gotham Asset Management, LLC, STATE STREET CORP, MACKENZIE FINANCIAL CORP, Bank of New York Mellon Corp, and DIMENSIONAL FUND ADVISORS LP.
This page lists
185
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.